Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL^pro): an in silico screening of alkaloids and terpenoids from African medicinal plants

References

• Aanouz, I., Belhassan, A., El Khatabi, K., Lakhlifi, T., El Idrissi, M., & Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations. Journal of Biomolecular Structure and Dynamics (just-accepted), 1–12.
   PubMed Web of Science ®Google Scholar
• Amoa Onguéné, P., Ntie-Kang, F., Lifongo, L. L., Ndom, J. C., Sippl, W., & Mbaze, L. M. (2013). The potential of anti-malarial compounds derived from African medicinal plants, part I: A pharmacological evaluation of alkaloids and terpenoids. Malaria Journal, 12, 449. https://doi.org/10.1186/1475-2875-12-449
   PubMed Web of Science ®Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.).), 300(5626), 1763–1767. https://doi.org/10.1126/science.1085658
   PubMed Web of Science ®Google Scholar
• Berry, M., Fielding, B. C., & Gamieldien, J. (2015). Potential broad spectrum inhibitors of the coronavirus 3CLpro: A virtual screening and structure-based drug design study. Viruses , 7(12), 6642–6660. https://doi.org/10.3390/v7122963
   PubMed Web of Science ®Google Scholar
• Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 Coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics (just-accepted), 1–14.
   PubMed Web of Science ®Google Scholar
• Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). StatPearls [Internet]. StatPearls Publishing.
   Google Scholar
• Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., Hayden, F. G., & Yuen, K.-Y. (2013). Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. The Journal of Infection, 67(6), 606–616. https://doi.org/10.1016/j.jinf.2013.09.029
   PubMed Web of Science ®Google Scholar
• Chen, Y. W., Yiu, C.-P B., & Wong, K.-Y. (2020). Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research, 9, 129. https://doi.org/10.12688/f1000research.22457.1
   PubMedGoogle Scholar
• Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/10.1021/ci300367a
   PubMed Web of Science ®Google Scholar
• de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014). Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrobial Agents and Chemotherapy, 58(8), 4875–4884. https://doi.org/10.1128/aac.03011-14
   PubMed Web of Science ®Google Scholar
• Dong, E., Du, H., & Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(20)30120-1
   Google Scholar
• Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., Johansen, L. M., Lear-Rooney, C. M., Glass, P. J., Hensley, L. E., & Frieman, M. B. (2014). Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy, 58(8), 4885–4893. https://doi.org/10.1128/aac.03036-14
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A., & Azzam, E. B. (2020). Novel Guanosine Derivatives against MERS CoV polymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–12.
   PubMed Web of Science ®Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–12.
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1751300
   PubMedGoogle Scholar
• Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., & Mehrabi, M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–13.
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, S., Shin, D. H., & Kim, M.-S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 145–151. https://doi.org/10.1080/14756366.2019.1690480
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G., Jain, M., Singh, E., Pathak, A., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2’-O-ribosemethyltransferase. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–40.
   Web of Science ®Google Scholar
• Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2020.1751298
   Web of Science ®Google Scholar
• Lessene, G., Czabotar, P. E., Sleebs, B. E., Zobel, K., Lowes, K. N., Adams, J. M., Baell, J. B., Colman, P. M., Deshayes, K., Fairbrother, W. J., Flygare, J. A., Gibbons, P., Kersten, W. J. A., Kulasegaram, S., Moss, R. M., Parisot, J. P., Smith, B. J., Street, I. P., Yang, H., Huang, D. C. S., & Watson, K. G. (2013). Structure-guided design of a selective BCL-X(L) inhibitor. Nature Chemical Biology, 9(6), 390–397. https://doi.org/10.1038/nchembio.1246
   PubMed Web of Science ®Google Scholar
• Li, J. Y., You, Z., Wang, Q., Zhou, Z. J., Qiu, Y., Luo, R., & Ge, X. Y. (2020). The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes and Infection, 22(2), 80–85. https://doi.org/10.1016/j.micinf.2020.02.002
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249. https://doi.org/10.1016/S1056-8719(00)00107-6
   PubMed Web of Science ®Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–7.
   PubMed Web of Science ®Google Scholar
• Ndhlala, A. R., Amoo, S. O., Ncube, B., Moyo, M., Nair, J. J., & Van Staden, J. (2013). Antibacterial, antifungal, and antiviral activities of African medicinal plants. In Medicinal plant research in Africa (pp. 621–659): Elsevier.
   Google Scholar
• Nickel, J., Gohlke, B.-O., Erehman, J., Banerjee, P., Rong, W. W., Goede, A., Dunkel, M., & Preissner, R. (2014). SuperPred: Update on drug classification and target prediction. Nucleic Acids Research, 42(Web Server issue), W26–31. https://doi.org/10.1093/nar/gku477
   PubMed Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33https://doi.org/10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• Osafo, N., Mensah, K. B., & Yeboah, O. K. (2017). Phytochemical and pharmacological review of Cryptolepis sanguinolenta (Lindl.) schlechter. Adv Pharmacol Sci, 2017, 3026370https://doi.org/10.1155/2017/3026370
   PubMed Web of Science ®Google Scholar
• Pant, S., Singh, M., Ravichandiran, V., Murty, U., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–15.
   PubMed Web of Science ®Google Scholar
• Pelz, N. F., Bian, Z., Zhao, B., Shaw, S., Tarr, J. C., Belmar, J., Gregg, C., Camper, D. V., Goodwin, C. M., Arnold, A. L., Sensintaffar, J. L., Friberg, A., Rossanese, O. W., Lee, T., Olejniczak, E. T., & Fesik, S. W. (2016). Discovery of 2-indole-acylsulfonamide myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods. J. Med. Chem, 59(5), 2054–2066. https://doi.org/10.1021/acs.jmedchem.5b01660
   PubMed Web of Science ®Google Scholar
• Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S. H. (2016). An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. Journal of Medicinal Chemistry, 59(14), 6595–6628. https://doi.org/10.1021/acs.jmedchem.5b01461
   PubMed Web of Science ®Google Scholar
• Sanchez-Linares, I., Perez-Sanchez, H., Cecilia, J. M., & Garcia, J. M. (2012). High-Throughput parallel blind Virtual Screening using BINDSURF. BMC Bioinformatics, 13(Suppl 14), S13. https://doi.org/10.1186/1471-2105-13-s14-s13
   PubMed Web of Science ®Google Scholar
• Sang, P., Tian, S., Meng, Z., Yang, L. (2020). Insight derived from molecular docking and molecular dynamics simulations into the binding interactions between HIV-1 protease inhibitor s and SARS-CoV-2 3CLpro. Preprint. https://chemrxiv.org/articles/Insight_Derived_from_Molecular_Docking_and_Molecular_Dynamics_Simulations_into_the_Binding_Interactions_Between_HIV-1_Protease_Inhibitors_and_SARS-CoV-2_3CLpro/11932995/1.
   Google Scholar
• Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., & Dhibar, D. P. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–11.
   PubMed Web of Science ®Google Scholar
• Setzer, W. N., Holland, M. T., Bozeman, C. A., Rozmus, G. F., Setzer, M. C., Moriarity, D. M., Reeb, S., Vogler, B., Bates, R. B., & Haber, W. A. (2001). Isolation and frontier molecular orbital investigation of bioactive quinone-methide triterpenoids from the bark of Salacia petenensis. Planta Medica, 67(1), 65–69. https://doi.org/10.1055/s-2001-10879
   PubMed Web of Science ®Google Scholar
• Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., Huang, D. C. S., Hymowitz, S. G., Jin, S., Khaw, S. L., Kovar, P. J., Lam, L. T., Lee, J., Maecker, H. L., Marsh, K. C., … Elmore, S. W. (2013). ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nature Medicine, 19(2), 202–208. https://doi.org/10.1038/nm.3048
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Ul Qamar, M. T., Alqahtani, S. M., Alamri, M. A., & Chen, L.-L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis. https://doi.org/10.1016/j.jpha.2020.03.009
   Google Scholar
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• Who, W.-C J. (2020). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva 2020.
   Google Scholar
• Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2020.02.008
   Google Scholar
• Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., & Zhu, W. (2020). Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv, 1, 0–2.
   Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Zhao, Q., Li, S., Xue, F., Zou, Y., Chen, C., Bartlam, M., & Rao, Z. (2008). Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1. Journal of Virology, 82(17), 8647–8655. https://doi.org/10.1128/jvi.00298-08
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., … Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S., & Yuen, K. Y. (2016). Coronaviruses - drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347. https://doi.org/10.1038/nrd.2015.37
   PubMed Web of Science ®Google Scholar